March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...

Weight Watchers says its GLP-1 Success Program plus meds delivers significantly more weight loss than meds alone, but evidence on keeping weight off ...

A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...

Consumers filed over 200 complaints with some telemedicine companies for misleading customers about costs of weight loss using GLP-1 drugs.

A coalition of Hispanic health and public policy organizations is pushing for New Mexico’s Medicaid program to broaden its coverage of weight loss drugs as treatment for obesity. The policy change, ...

An Informational Analysis of TrimRx Compounded Semaglutide and Tirzepatide Programs, Telehealth Prescription Process, ...

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...

Eli Lilly warns some Medicare plans may exceed the $50 monthly cap for weight‑loss drugs under a new CMS model.

The conversation around weight loss has changed dramatically over the past few years. Medications such as semaglutide and tirzepatide—often referred to as GLP-1 therapies—have dominated headlines, ...

Raleigh Weight Loss Center warns of GLP-1 medication risks & offers safe, natural weight loss solutions focusing on ...

Medicare had banned coverage of weight-loss drugs for 23 years, and what happens next isn't as simple as the headlines ...

Kroger said it is now stocking Eli Lilly's injection pen version of the weight-loss drug Zepbound, and will allow self-pay customers to use Lilly's savings card at its retail pharmacies. The ...